Impact and credibility of the WHO adverse reaction signals

Drug Information Journal

Volumn 30, Issue 2, 1996, Pages 461-464

  Fucik, Helena ^a   Edwards, I Ralph ^a  

^a WHO Collaborating Ctr Intl Drug M   (Sweden)

Author keywords

Adverse drug reactions; Drug monitoring; WHO

Indexed keywords

DRUG;

ALERTNESS; ARTICLE; DATA BASE; DRUG CONTRAINDICATION; DRUG MONITORING; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; SIDE EFFECT; SWEDEN; WORLD HEALTH ORGANIZATION;

EID: 0029885854     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159603000216     Document Type: Article

References (9)

1. Olsson S, Edwards IR. Tachycardia during cisapride treatment. Br Med J. 1992;305:748-749.
2. Inman W, Kubota K. Tachycardia during cisapride treatment. Br Med J. 1992;305:1019.
3. Usha Rani P, Naidu M, Ramesh-Kumar T, Shobha U, Kumar JC and A. Tachycardia during cisapride treatment. Indian J Pharmacol. 1994;26:233-234.
4. Ahmad SR, Wolfe SM. Cisapride and torsades de pointes. Lancet. 1995;345:508.
5. Smith GW, Hurst NP. Vasculitis, Raynaud's Phenomenon and Polyarthritis associated with gemfibrozil therapy. Br J Rheumatol. 1993;32:84-85.
6. Lindquist M, Edwards IR. Endocrine adverse effects of omeprazole. Br Med J. 1992;305:451-452.
7. Durand JM, Cretel E, Kaplanski G, Soubeyrand J. Gynécomastie et traitment par oméprazole. Révenue de Méd Int. 1993;14:1139.
8. Pedrosa M, Sancho A, Benavent J, Casajuana J. Ginecomastia inducida por omeprazol. Med Clinica. 1994;102:435.
9. Cavazos JE, Caress JB, Chilukuri VR, Devlin T, Gray L, Hurwitz BJ. Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet. 1994;343:1105-1106.